Xeris Biopharma (XERS) Q3 2026 Earnings

6AugConfirmed
Q3 2025
Q4 2025
Q2 2026
Q3 2026
-0.18
-0.12
-0.05
0.01

Details

Expected EPS
0.012143
Actual EPS
-0.18
Surprise EPS
-0.19
Surprise Percent
+1,582.34%

Description

Xeris Biopharma (XERS) has reported earnings of -0.18 per share for Q3 2026.

0 Comments

Share your thoughts